Global Biomarkers Market

Global biomarkers market by product (consumables, instruments, services, software), by technology (genomics, proteomics, metabolomics, imaging, others), by disease (cancer, cardiovascular and metabolic diseases, neurodegenerative diseases, infectious diseases, autoimmune diseases, others), by end user (biopharmaceutical and biotech companies, CROs, hospitals and diagnostics, research and academic institutes), by region (Emerging Region, Europe, North America), outlook & forecast, 2022-2028

SKU: GB02239R Category: Region:

USD2,600.00

Description

A biomarker is a biological characteristic that is objectively measured and evaluated as an indicator of normal biological or pathological processes, or a response to a therapeutic intervention. Examples include patterns of gene expression, levels of a particular protein in body fluids, or changes in electrical activity in the brain. According to latest analysis by Gen Consulting Company, the global biomarkers market is poised to grow by USD 48 billion during 2022-2028, progressing at a CAGR of 12.3% during the forecast period.

The report provides in-depth analysis and insights regarding the current global market scenario, latest trends and drivers into global biomarkers market. It offers an exclusive insight into various details such as market size, key trends, competitive landscape, growth rate and market segments. This study also provides an analysis of the impact of the COVID-19 crisis on the biomarkers industry.

This industry report offers market estimates and forecasts of the global market, followed by a detailed analysis of the product, technology, disease, end user, and region. The global market for biomarkers can be segmented by product: consumables, instruments, services, software. The consumables segment held the largest share of the global biomarkers market in 2021 and is anticipated to hold its share during the forecast period. Biomarkers market is further segmented by technology: genomics, proteomics, metabolomics, imaging, others. Globally, the proteomics segment made up the largest share of the biomarkers market. Based on disease, the biomarkers market is segmented into: cancer, cardiovascular and metabolic diseases, neurodegenerative diseases, infectious diseases, autoimmune diseases, others. The cancer segment was the largest contributor to the global biomarkers market in 2021. On the basis of end user, the biomarkers market also can be divided into: biopharmaceutical and biotech companies, CROs, hospitals and diagnostics, research and academic institutes. The hospitals and diagnostics segment is estimated to account for the largest share of the global biomarkers market. Biomarkers market by region is categorized into: Emerging Region, Europe, North America.

By product:
– consumables
– instruments
– services
– software

By technology:
– genomics
– proteomics
– metabolomics
– imaging
– others

By disease:
– cancer
– cardiovascular and metabolic diseases
– neurodegenerative diseases
– infectious diseases
– autoimmune diseases
– others

By end user:
– biopharmaceutical and biotech companies
– CROs
– hospitals and diagnostics
– research and academic institutes

By region:
– Emerging Region
– Europe
– North America

The global biomarkers market report offers detailed information on several market vendors, including Abbott Laboratories Inc., Agilent Technologies Inc., Bayer AG, Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Bio-Techne Corp., Bruker Corp., Canon Medical Systems Corporation, Danaher Corporation, F. Hoffmann-La Roche Ltd, FUJIFILM VisualSonics Inc., GE Healthcare, Illumina, Inc., JEOL Ltd., Koninklijke Philips N.V., Oxford Nanopore Technologies Limited, PerkinElmer, Inc., QIAGEN N.V., Shimadzu Corporation, Siemens Healthineers AG, Thermo Fisher Scientific Inc., Waters Corporation, among others.
*REQUEST FREE SAMPLE TO GET A COMPLETE LIST OF COMPANIES

Historical & Forecast Period
This research report provides analysis for each segment from 2018 to 2028 considering 2021 to be the base year.

Scope of the Report
– To analyze and forecast the market size of the global biomarkers market.
– To classify and forecast the global biomarkers market based on product, technology, disease, end user, region.
– To identify drivers and challenges for the global biomarkers market.
– To examine competitive developments such as mergers & acquisitions, agreements, collaborations and partnerships, etc., in the global biomarkers market.
– To identify and analyze the profile of leading players operating in the global biomarkers market.

Why Choose This Report
– Gain a reliable outlook of the global biomarkers market forecasts from 2022 to 2028 across scenarios.
– Identify growth segments for investment.
– Stay ahead of competitors through company profiles and market data.
– The market estimate for ease of analysis across scenarios in Excel format.
– Strategy consulting and research support for three months.
– Print authentication provided for the single-user license.

Want to customize this report?

This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time.
Interested in this report? Get your FREE sample now!
Global Biomarkers Market

Please fill out our form and we will get back to you.